Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;29(12):2396-2400.
doi: 10.1158/1055-9965.EPI-20-1158.

The National Cancer Institute Early Detection Research Network: Two Decades of Progress

Robert C Bast Jr  1 , Sudhir Srivastava  2
Affiliations
Review

The National Cancer Institute Early Detection Research Network: Two Decades of Progress

Robert C Bast Jr et al. Cancer Epidemiol Biomarkers Prev. 2020 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Dr. Bast receives royalties from Fujirebio Diagnostics Inc. for the discovery of CA125.

References

    1. Srivastava S, Wagner PD. The Early Detection Research Network: A national infrastructure to support the discovery development and validation of cancer biomarkers. Cancer Epidemiol Biomarkers Prev 2020; (this issue) - PMC - PubMed
    1. Ostrin E, Sidransky D, Spira A, Hanash S. Biomarkers for lung cancer screening and detection. Cancer Epidemiol Biomarkers Prev 2020; (this issue) - PMC - PubMed
    1. Silvestri GA, Tanner NT, Kearney P, Vachani A, Massion PP, Porter A, et al. Assessment of plasma proteomics biomarker’s ability to distinguish benign from malignant lung nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) trial. Chest 2018; 154:491–500. doi 10.1016/j.chest.2018.02.012. - DOI - PMC - PubMed
    1. Massion PP, Healey GF, Peek LJ, Fredericks L, Sewell HF, Murray A, et al. Autoantibody signature enhances the positive predictive power of computed tomography and nodule-based risk models for detection of lung cancer. J Thoracic Oncol, 2017. 12:578–584. - PMC - PubMed
    1. Edelsberg J, Weycker D, Atwood M, Hamilton-Fairley G, Jett JR. Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules. PloS one 2018;13(5):e0197826doi 10.1371/journal.pone.0197826. - DOI - PMC - PubMed

Publication types